Oda, Naohiro
Hotta, Katsuyuki
Yoshioka, Hiroshige
Kudo, Kenichiro
Ichihara, Eiki
Kato, Yuka
Ninomiya, Kiichiro
Minami, Daisuke
Ninomiya, Takashi
Kubo, Toshio
Ohashi, Kadoaki
Sato, Akiko
Takigawa, Nagio
Tabata, Masahiro
Tanimoto, Mitsune
Kiura, Katsuyuki
Article History
Received: 9 May 2016
Accepted: 23 August 2016
First Online: 2 September 2016
Compliance with ethical standards
:
: KH has received honoraria from AstraZeneca, Eli Lilly Japan, Daiichi-Sankyo Pharmaceutical, Boehringer-Ingelheim, Nihon Kayaku, Taiho Pharmaceutical, and Chugai Pharmaceutical. KH also has received research funding from Eli Lilly Japan, MSD, and Chugai Pharmaceutical. HY received honoraria from AstraZeneca, Chugai Pharmaceutical, Boehringer-Ingelheim in Japan, and Eli Lilly Japan. NT has received honoraria from AstraZeneca, Daiichi-Sankyo Pharmaceutical, Chugai Pharmaceutical, Taiho Pharmaceutical, Pfizer Inc. Japan, Boehringer-Ingelheim in Japan, Eisai, and Kyowa-Hakko Kirin. NT also received research donated funds from Nihon Kayaku, AstraZeneca, Chugai Pharmaceutical, Taiho Pharmaceutical, Pfizer Inc. Japan, Boehringer-Ingelheim in Japan, and Kyowa-Hakko Kirin. KK has received honoraria from Eli Lilly Japan, Nihon Kayaku, AstraZeneca, Daiichi-Sankyo Pharmaceutical, Chugai Pharmaceutical, Taiho Pharmaceutical, and Sanofi-Aventis. All other authors declare that they have no conflicts of interest relating to this study.